Mirum Pharmaceuticals (MIRM) Non Operating Income (2019 - 2025)
Mirum Pharmaceuticals' quarterly Non Operating Income came in at -$218000.0 in Q4 2025, down 194.37% year-on-year from $231000.0 in Q4 2024, and down 155.19% quarter-over-quarter from $395000.0 in Q3 2025.
Mirum Pharmaceuticals has reported Non Operating Income for 7 years, with the latest figure at -$218000.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income fell 194.37% year-over-year to -$218000.0; the trailing twelve-month figure through Mar 2026 stood at $263000.0 (down 83.18% YoY), and the FY2025 full-year result was $2.4 million, up 95.47% from the prior year.
- Non Operating Income for Q4 2025 stood at -$218000.0, down from $395000.0 in the prior quarter.
- The five-year high for Non Operating Income was $2.1 million in Q1 2025, with the low at -$3.1 million in Q4 2023.
- Average Non Operating Income over 5 years is $27150.0, with a median of -$26000.0 recorded in 2021.
- Year-over-year, Non Operating Income slumped 3358.82% in 2022 and jumped 788.54% in 2023.
- Tracing MIRM's Non Operating Income over 5 years: stood at -$17000.0 in 2021, then tumbled by 3358.82% to -$588000.0 in 2022, then slumped by 420.58% to -$3.1 million in 2023, then surged by 107.55% to $231000.0 in 2024, then plunged by 194.37% to -$218000.0 in 2025.
- The last three Non Operating Income figures came in at -$218000.0 (Q4 2025), $395000.0 (Q3 2025), and $86000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -218,000.00 |
| Sep 30, 2025 | 395,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 231,000.00 |
| Sep 30, 2024 | -1.09 Mn |
| Jun 30, 2024 | 312,000.00 |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | -3.06 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | -274,000.00 |
| Mar 31, 2023 | -811,000.00 |
| Dec 31, 2022 | -588,000.00 |
| Sep 30, 2022 | -192,000.00 |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | -154,000.00 |
| Dec 31, 2021 | -17,000.00 |
| Sep 30, 2021 | -35,000.00 |
| Jun 30, 2021 | -514,000.00 |
| Mar 31, 2021 | -16,000.00 |
| Dec 31, 2020 | -83,000.00 |
| Sep 30, 2020 | -30,000.00 |
| Jun 30, 2020 | -56,000.00 |
| Mar 31, 2020 | -23,000.00 |
| Dec 31, 2019 | -20,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Jun 30, 2019 | 9,000.00 |
| Mar 31, 2019 | -5,000.00 |